Tag: Medicare Part B reimbursement
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Pregnancy and Sleep: How to Manage Apnea, Reflux, and Positioning for Better Rest
Mar, 18 2026
Ocular Trauma: Chemical Splashes and Immediate First Aid
Dec, 28 2025
How Generic Drugs Saved the U.S. Healthcare System $3.4 Trillion
May, 25 2026
Cannabis and Medications: What You Need to Know About Drug Interactions
Nov, 28 2025
How to Store Controlled Substances to Prevent Diversion: A Practical Guide for Healthcare Facilities
Nov, 16 2025